cbdMD’s Paw CBD Animal Health Brand Wins 2021 Pet Product News Editor’s Choice Award | News

CHARLOTTE, North Carolina, January 28, 2022 /PRNewswire-PRWeb/ — Paw CBD, a division of cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the most trusted, trusted and recognized brands of CBD, today announced that Paw CBD had won a 2021 Editor’s Choice Award from Pet Product News for its baked treats for dogs.

For more than 15 years, Pet Product News’ (PPN) annual Editors’ Choice Awards have been among the most anticipated in the pet products industry. Because their goal is to showcase the “newest and best” products, receiving an Editor’s Choice Award is a testament not only to innovation, but also to meeting and exceeding needs and expectations. pet owners in a highly competitive multi-billion dollar market. Pet Product News editors review countless products each year and select only the best of the best, officially recognizing the “must haves” for the pets in our lives.

“We are honored to receive this coveted recognition from Pet Product News, which recognizes the newest and most innovative products in the pet industry,” said Matt Coapman, Marketing Director for CBDMD and Paw CBD. “Paw CBD is founded on the belief that pets are family too, so everything we do is done with love and to provide them with the best care we can give them. All of our premium hemp-derived products for cats and dogs are carefully crafted and specially formulated to support their health and happiness, including this travel bag of our popular treats that makes it easy to add CBD to a dog’s daily routine, even on the go.

Paw CBD Travel Size Dog Chews offer a convenient, crunchy way to serve superior formula, broad-spectrum cannabidiol (CBD) for everyday wellness. Small and portable, this five-piece bag is the perfect travel companion, and dogs love the peanut butter flavor. Chews are made with lab-tested, ISO-certified hemp for safety, human-grade ingredients, and no artificial fillers or flavors.

About CBDMD, Inc.

cbdMD, Inc. is one of the most trusted and trusted cannabidiol (CBD) brands, with a full line of THC1-free CBD products produced in the USA. The cbdMD brand currently includes over 130 SKUs of premium CBD products, including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD bath bombs, CBD bath salts, CBD sleeping pills , CBD drink mixes, and full-spectrum CBD options. Our cbdMD Botanicals brand of beauty and skincare products includes 15 SKUs, including facial oils and serums, toners, moisturizers, clear skin, face masks, exfoliators and body treatments. To learn more about cbdMD and their full line of USA-grown, THC1-free CBD oil and full-spectrum products, please visit http://www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 outlets. who sell CBDMD products.

About Paw CBD

Paw CBD is a nationally recognized brand of cannabidiol (CBD) for pets, offering over 40 consumable pet products that combine the properties of CBD oil with “pet-approved” flavors “like peanut butter, catnip, and turkey. Paw CBD is one of the fastest growing brands in CBD for pets. To learn more about Paw CBD’s full line of non-THC1 pet products, please visit pawcbd.com or follow Paw CBD on Instagram and Facebook.

1 THC-Free is defined as below the level of detection using validated scientific analytical methods.

Forward-looking statements

This press release contains certain forward-looking statements that are based on current expectations and involve certain risks and uncertainties within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of words such as ‘ ‘should,’ ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”plans,” ”plans,” ”expects”, ”plans” and ”proposes”. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or anticipated in the forward-looking statements. You are urged to carefully review and consider all cautionary and other information, including statements made under “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the financial year closed September 30, 2021 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, many of which are generally beyond the control of cbdMD, Inc. and are difficult to predict. CBDMD, Inc. assumes no obligation to update forward-looking statements except as required by law. Information that appears on our websites and social media platforms, including but not limited to Instagram and Facebook, is not part of this press release.




Robert Pettway

Public Relations Director

[email protected]

(423) 503-5225



John Weston

Investor Relations Director

[email protected]

(704) 249-9515

Media Contact

Robert PettwaycbdMD, (423) 503-5225, [email protected]



Boyd S. Abbott